Adprotech company
Adprotech is develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection.
Last Funding Type:
Series B
Headquarters:
Saffron Walden, Essex, United Kingdom
Investors Number:
2
Technology:
Regenerative Medicine
Industry:
Biotechnology, Health Care, Science and Engineering
Funding Status:
M&A
Total Funding:
$27.2M